Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 202

1.

Prolonged Length of Stay after Esophageal Resection: Identifying Drivers of Increased Length of Stay Using the NSQIP Database.

Park KU, Rubinfeld I, Hodari A, Hammoud Z.

J Am Coll Surg. 2016 Mar 31. pii: S1072-7515(16)30032-1. doi: 10.1016/j.jamcollsurg.2016.03.029. [Epub ahead of print]

PMID:
27118713
2.

Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.

Choi YS, Park SG, Song EK, Cho SH, Park MR, Park KU, Lee KH, Song IC, Lee HJ, Jo DY, Kim S, Yun HJ; Korean South West Oncology Group (KSWOG) Investigators.

Head Neck. 2016 Apr 4. doi: 10.1002/hed.24438. [Epub ahead of print]

PMID:
27043228
3.

Genotyping of 22 blood group antigen polymorphisms and establishing a national recipient registry in the Korean population.

Hong YJ, Chung Y, Hwang SM, Park JS, Kwon JR, Choi YS, Kim JN, Lee DH, Kwon SY, Cho NS, Song EY, Park KU, Song J, Han KS.

Ann Hematol. 2016 Mar 28. [Epub ahead of print]

PMID:
27021300
4.

BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.

Nam SK, Yun S, Koh J, Kwak Y, Seo AN, Park KU, Kim DW, Kang SB, Kim WH, Lee HS.

PLoS One. 2016 Mar 18;11(3):e0151865. doi: 10.1371/journal.pone.0151865. eCollection 2016.

5.

Small-Colony Variants in Persistent and Recurrent Staphylococcus aureus Bacteremia.

Kim NH, Kang YM, Han WD, Park KU, Park KH, Yoo JI, Lee DG, Park C, Song KH, Kim ES, Park SW, Kim NJ, Oh MD, Kim HB.

Microb Drug Resist. 2016 Mar 16. [Epub ahead of print]

PMID:
26982169
6.

Cytokine-release kinetics of platelet-rich plasma according to various activation protocols.

Roh YH, Kim W, Park KU, Oh JH.

Bone Joint Res. 2016 Feb;5(2):37-45. doi: 10.1302/2046-3758.52.2000540.

PMID:
26862077
7.

Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck.

Huang KK, Jang KW, Kim S, Kim HS, Kim SM, Kwon HJ, Kim HR, Yun HJ, Ahn MJ, Park KU, Ramnarayanan K, McPherson JR, Zhang S, Rhee JK, Vettore AL, Das K, Ishimoto T, Kim JH, Koh YW, Kim SH, Choi EC, Teh BT, Rozen SG, Kim TM, Tan P, Cho BC.

Sci Rep. 2016 Jan 21;6:19552. doi: 10.1038/srep19552.

8.

Infected Aortic Aneurysm caused by Mycobacterium bovis after Intravesical Bacillus Calmette-Guérin Treatment for Bladder Cancer.

Nam EY, Na SH, Kim SY, Yoon D, Kim CJ, Park KU, Min SK, Lee SE, Choe PG.

Infect Chemother. 2015 Dec;47(4):256-60. doi: 10.3947/ic.2015.47.4.256. Epub 2015 Dec 30.

9.

Impact of the multiplex polymerase chain reaction in culture-positive samples on appropriate antibiotic use in patients with staphylococcal bacteremia.

Na SH, Kim CJ, Kim M, Park JS, Song KH, Choe PG, Park WB, Bang JH, Kim ES, Park SW, Park KU, Kim NJ, Oh MD, Kim HB.

Diagn Microbiol Infect Dis. 2016 Apr;84(4):353-7. doi: 10.1016/j.diagmicrobio.2015.12.007. Epub 2015 Dec 17.

PMID:
26778485
10.

Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review.

Ahn MJ, D'Cruz A, Vermorken JB, Chen JP, Chitapanarux I, Dang HQ, Guminski A, Kannarunimit D, Lin TY, Ng WT, Park KU, Chan AT.

Oral Oncol. 2016 Feb;53:10-6. doi: 10.1016/j.oraloncology.2015.11.019. Epub 2015 Dec 19. Review.

11.

Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02).

Lee JY, Sun JM, Oh DR, Lim SH, Goo J, Lee SH, Kim SB, Park KU, Kim HK, Hong DS, Kim JS, Kim SG, Yi SY, Yun HJ, Hyun MS, Kim HJ, Jung SH, Park K, Ahn YC, Ahn MJ.

Radiother Oncol. 2016 Feb;118(2):244-50. doi: 10.1016/j.radonc.2015.11.030. Epub 2015 Dec 17.

PMID:
26705681
12.

Clinical and Molecular Characterization of Invasive Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Infections in Korean Hospitals.

Kim ES, Bae IG, Cho JE, Choi YJ, Kim IH, Kang GS, Sin HY, Song KH, Park C, Lee DG, Kim M, Park KU, Kim HB.

J Clin Microbiol. 2016 Mar;54(3):760-3. doi: 10.1128/JCM.02595-15. Epub 2015 Dec 16.

PMID:
26677256
13.

The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves' Disease.

Cho SW, Bae JH, Noh GW, Kim YA, Moon MK, Park KU, Song J, Yi KH, Park DJ, Chung JK, Cho BY, Park YJ.

PLoS One. 2015 Dec 9;10(12):e0144599. doi: 10.1371/journal.pone.0144599. eCollection 2015.

14.

Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.

Song KH, Kim HB, Kim HS, Lee MJ, Jung Y, Kim G, Hwang JH, Kim NH, Kim M, Kim CJ, Choe PG, Chung JY, Park WB, Kim ES, Park KU, Kim NJ, Kim EC, Oh MD.

Int J Antimicrob Agents. 2015 Dec;46(6):689-95. doi: 10.1016/j.ijantimicag.2015.09.010. Epub 2015 Oct 17.

PMID:
26555059
15.

Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.

Kim HJ, Shin SW, Song EK, Lee NR, Kim JS, Ahn JS, Yun HJ, Cho YH, Park KU, Kim SY, Jang JS, Kim SW, Lee HW, Lee SR, Kim YS, Lee SN, Ko YH, Kim HJ, Kang JH.

Oncologist. 2015 Dec;20(12):1440-7. doi: 10.1634/theoncologist.2015-0128. Epub 2015 Oct 28.

PMID:
26512046
16.

Comparison of the Cellular Composition and Cytokine-Release Kinetics of Various Platelet-Rich Plasma Preparations.

Oh JH, Kim W, Park KU, Roh YH.

Am J Sports Med. 2015 Dec;43(12):3062-70. doi: 10.1177/0363546515608481. Epub 2015 Oct 15.

PMID:
26473014
17.

Novel Use of External Tissue Expander for Management of Sternal Wound Dehiscence.

Park KU, Moquin K.

Ann Thorac Surg. 2015 Oct;100(4):e81-3. doi: 10.1016/j.athoracsur.2015.06.044.

PMID:
26434485
18.

A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.

Lee KH, Kim JY, Lee MH, Han HS, Lim JH, Park KU, Park IH, Cho EK, Yoon SY, Kim JH, Choi IS, Park JH, Choi YJ, Kim HJ, Jung KH, Kim SY, Oh DY, Im SA.

Support Care Cancer. 2016 Apr;24(4):1709-17. doi: 10.1007/s00520-015-2963-7. Epub 2015 Oct 1.

19.

A Muti-center, Randomized Phase II Study of Oxaliplatin and S-1 versus Capecitabine and Oxaliplatin in Patients with Metastatic Colorectal Cancer.

Kim JH, Zang DY, Chung IJ, Cho SH, Park KU, Oh HS, Lee KH, Lee BH, Kim MJ, Park CK, Han B, Kim HS, Choi DR, Song HH, Jung JY.

J Cancer. 2015 Aug 29;6(10):1041-8. doi: 10.7150/jca.12819. eCollection 2015.

20.

Direct assay of iduronate-2-sulfatase for Hunter disease using UPLC-tandem mass spectrometry and fluorogenic substrate.

Lee K, Jun SH, Song SH, Park HD, Park KU, Song J.

Clin Biochem. 2015 Dec;48(18):1350-3. doi: 10.1016/j.clinbiochem.2015.08.016. Epub 2015 Aug 18.

PMID:
26297117
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk